Clinical trial · Observational

Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms

Aquagenic Pruritus Among Patients With Myeloproliferative Syndromes (in English) Prurit Aquagénique Dans Les SYndromes MyéloProLifEratifs (in French)

NCT03688490CI-TRIAL-00039267PASYMPLEcompletedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

Description of the characteristics of aquagenic pruritus expressed by patients suffering from myeloproliferative neoplasms. Prospective work based on the distribution of a dedicated questionnaire.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Myeloproliferative Disorder	Myeloproliferative Neoplasm	ALIAS	0.90

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Design

Arms and outcomes

Arms (0)

[]

Primary outcomes (1)

measure
Intensity of the pruritus
timeFrame
15 days
description
Analogic Visual Scale, from 0 to 10, Worse if \>6

Secondary outcomes (1)

measure
Duration of the pruritus
timeFrame
15 days
description
Timing expresses in minutes

Eligibility

Eligibility (as posted)

Sex: All

Show eligibility criteria text

Inclusion Criteria:

* patients followed with myeloproliferative neoplasms
* suffering from aquagenic pruritus

Exclusion Criteria:

* Unable to fulfil the questionnaire
* No written informed consent

References

Publications (1)

RESULTLe Gall-Ianotto C, Brenaut E, Gouillou M, Lacut K, Nowak E, Tempescul A, Berthou C, Ugo V, Carre JL, Misery L, Ianotto JC. Clinical characteristics of aquagenic pruritus in patients with myeloproliferative neoplasms. Br J Dermatol. 2017 Jan;176(1):255-258. doi: 10.1111/bjd.14809. Epub 2016 Dec 22. No abstract available. PMID 27291777